Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.02 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.02 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |